MPAA(MPAA)
MPAA
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|
| Revenue Avg | $800M | $861M | $904M | $1.01B |
| Low | $797M | $858M | $901M | $1.01B |
| High | $803M | $864M | $907M | $1.02B |
| EBITDA Avg | $81M | $88M | $92M | $103M |
| Low | $81M | $87M | $92M | $103M |
| High | $82M | $88M | $92M | $104M |
| EBIT Avg | $79M | $85M | $89M | $100M |
| Low | $79M | $85M | $89M | $100M |
| High | $79M | $85M | $90M | $100M |
| Net Income Avg | $35M | $38M | $41M | $30M |
| Low | $35M | $38M | $41M | $30M |
| High | $35M | $38M | $41M | $30M |
| EPS Avg | $1.74 | $1.89 | $2.06 | $1.51 |
| Low | $1.73 | $1.88 | $2.05 | $1.50 |
| High | $1.75 | $1.90 | $2.07 | $1.52 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 2 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 |
|---|---|---|---|
| Revenue Avg | $203M | $195M | $220M |
| Low | $196M | $189M | $212M |
| High | $210M | $202M | $227M |
| EBITDA Avg | $21M | $20M | $22M |
| Low | $20M | $19M | $22M |
| High | $21M | $21M | $23M |
| EBIT Avg | $20M | $19M | $22M |
| Low | $19M | $19M | $21M |
| High | $21M | $20M | $22M |
| Net Income Avg | $8M | $13M | $13M |
| Low | $6M | $13M | $13M |
| High | $11M | $14M | $14M |
| EPS Avg | $0.36 | $0.59 | $0.58 |
| Low | $0.25 | $0.56 | $0.56 |
| High | $0.48 | $0.62 | $0.61 |
| Analysts (Rev / EPS) | 1 / 2 | 1 / 1 | 1 / 1 |